PLANO, Texas, Feb. 16, 2022 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics™), a national remote monitoring provider and technology leader in deep learning artificial intelligence, has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation by […]
Tag: MediLynx
MediLynx Cardiac Monitoring Partners with National Heart, Lung and Blood Institute & National Institutes of Health on Study of Efficacy of Mobile Cardiac Monitoring for Patients
PLANO, Texas, Feb. 8, 2022 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics™), a national remote monitoring provider and technology leader in deep learning artificial intelligence, today announced a groundbreaking partnership with the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes […]
MediLynx Announces Patent Awarded for Mobile ECG Streaming and Monitoring
PLANO, Texas, Jan. 5, 2022 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics) today announced that its parent company, MEDICALgorithmics S.A. (WSE: MDG) has received a broad patent (US Patent No. 11,183,305) for continuous (full-disclosure) ECG streaming, analysis and monitoring from […]
MediLynx Cardiac Monitoring, LLC introduces dedicated remote monitoring services based on its PocketECG® platform to support hospitals in managing COVID-19 patients in accordance with the latest FDA enforcement policy
PocketECG, MediLynx’s FDA approved remote monitoring systems: PocketECG Unified Arrhythmia Diagnostic System will be used for continuous streaming and analysis of full-disclosure ECG data, oxygen saturation, resting heart rate, patient symptoms and arrhythmia. The device is cleared by the FDA […]
MediLynx Cardiac Monitoring Awarded Patent for Remote ECG Monitoring With Full Disclosure ECG Signal Transmission
PLANO, Texas, May 16, 2019 /PRNewswire/ — MediLynx Cardiac Monitoring LLC today announced the company has received a patent for its PocketECG full-disclosure ECG monitoring and transmission technology with patient symptomatic event reporting for remote cardiac monitoring. The patent covers use of the […]
Study Finds Micro-AF is a Predictor of Clinical AF, Provides Guidance on ECG Monitoring Duration
PLANO, Texas, May 8, 2019 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC today announced new research connecting short episodes of Atrial Fibrillation called micro-AF (4 beats <29) with the presentation of clinical AF (>30 seconds). The study showed that 83% of patients with micro-AF […]